Cell Source, Inc.
CLCS · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $15,763 | $13,576 | $33 | $15,798 |
| - Cash | $75 | $23 | $91 | $0 |
| + Debt | $10,068 | $10,097 | $10,007 | $9,300 |
| Enterprise Value | $25,757 | $23,650 | $9,949 | $25,098 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$376 | -$912 | -$1,172 | -$1,132 |
| % Margin | – | – | – | – |
| Net Income | -$590 | -$1,417 | -$1,489 | -$1,275 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.021 | -0.042 | -0.045 | -0.04 |
| % Growth | 49.6% | 6.5% | -12.9% | – |
| Operating Cash Flow | -$748 | -$639 | -$1,123 | -$174 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$748 | -$639 | -$1,123 | -$174 |